European Journal of Neuroscience · 1994 · 510 citations · 42 references
Life SciencesNeurobiologyNeuroscienceNeurochemistryPain MedicinePharmacodynamicsNeuropathic MechanismsPain MechanismsPain NeurobiologyPain NeurophysiologyPain PhysiologyThermal Sensation5-Hydroxytryptamine Receptor PharmacologyMechanical HyperalgesiaNerve Growth Factor SignalingNmda Receptor AntagonismNmda Receptor PharmacologyNmda ReceptorsRadiant Heat ExposureThermal Hyperalgesia
Mechanisms underlying the hyperalgesia induced by a single systemic injection of nerve growth factor (NGF) in adult rats were studied in vivo. A single dose of NGF initiated a prolonged thermal hyperalgesia to a radiant heat source within minutes that lasted for days. Animals which had been pretreated with the mast cell degranulating compound 48/80 or either one of two specific 5-hydroxytryptamine receptor antagonists (ICS 205-930 and methiothepin) also developed an NGF-induced thermal hyperalgesia, but onset was delayed by more than 3 h. In the presence of ICS 205-930 or methiothepin the early component NGF-induced hyperalgesia was reversed and the animals responded with an initial hypoalgesia to the thermal stimuli. Whereas these results indicate a peripheral mechanism for the initial thermal hyperalgesia, the later phase (7 h-4 days after NGF) appeared to be centrally maintained, since it could be selectively blocked by the non-competitive NMDA receptor antagonist MK-801. In contrast to the almost immediate thermal hyperalgesia following a single injection of NGF, a significant mechanical hyperalgesia began only after a 7 h latency. This NGF-induced mechanical hyperalgesia was not blocked by any of the treatments that attenuated the thermal hyperalgesia, indicating that a separate mechanism may be involved. Additional electrophysiological experiments showed that NGF-induced hyperalgesia was not maintained by an increased amount of spontaneous activity in C-fibres. A final result showed that endogenous release of NGF in a model of acute inflammation (complete Freund's adjuvant-induced inflammation) may be involved in the development of thermal hyperalgesia, since it could be blocked by concomitant treatment with anti-NGF antisera. These data indicate that NGF-induced thermal and mechanical hyperalgesia are mediated by different mechanisms. The rapid onset component of thermal hyperalgesia is due to a peripheral mechanism involving the degranulation of mast cells, whereas the late component involves central NMDA receptors. In contrast, the NGF-induced mechanical hyperalgesia seems to be independent of mast cell degranulation or central NMDA receptor sites.
42
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Kenneth Hargreaves, Ronald Dubner, Frederick J. Brown et al. · Pain · 1988 · 5.2K citations
Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs
B. P. Richardson, G. Engel, P. Donatsch et al. · Nature · 1985 · 842 citations
Josef Donnerer, Rufina Schuligoi, Christoph Stein · Neuroscience · 1992 · 601 citations
Nerve growth factor-induced hyperalgesia in the neonatal and adult rat
AM Ritter · Journal of Neuroscience · 1993 · 559 citations · Full text